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Abstract
Background: Ultraviolet (UV) crosslinking and immunoprecipitation (CLIP) identifies the sites on RNAs that are in
direct contact with RNA-binding proteins (RBPs). Several variants of CLIP exist, which require different
computational approaches for analysis. This variety of approaches can create challenges for a novice user and can
hamper insights from multi-study comparisons. Here, we produce data with multiple variants of CLIP and evaluate
the data with various computational methods to better understand their suitability.
Results: We perform experiments for PTBP1 and eIF4A3 using individual-nucleotide resolution CLIP (iCLIP), employing
either UV-C or photoactivatable 4-thiouridine (4SU) combined with UV-A crosslinking and compare the results with
published data. As previously noted, the positions of complementary DNA (cDNA)-starts depend on cDNA length in
several iCLIP experiments and we now find that this is caused by constrained cDNA-ends, which can result from the
sequence and structure constraints of RNA fragmentation. These constraints are overcome when fragmentation by
RNase I is efficient and when a broad cDNA size range is obtained. Our study also shows that if RNase does not
efficiently cut within the binding sites, the original CLIP method is less capable of identifying the longer binding sites
of RBPs. In contrast, we show that a broad size range of cDNAs in iCLIP allows the cDNA-starts to efficiently delineate
the complete RNA-binding sites.
Conclusions: We demonstrate the advantage of iCLIP and related methods that can amplify cDNAs that truncate at
crosslink sites and we show that computational analyses based on cDNAs-starts are appropriate for such methods.
Keywords: Protein–RNA interactions, iCLIP, eCLIP, irCLIP, Binding site assignment, High-throughput sequencing,
Polypyrimidine tract binding protein 1 (PTBP1), Eukaryotic initiation factor 4A-III (eIF4A3), Exon-junction complex
Background
RNA-binding proteins (RBPs) play crucial roles in all
aspects of post-transcriptional gene regulation. To under-
stand the mechanisms of their action, it is essential to
identify the endogenous sites of protein–RNA interac-
tions, which has been aided by the development of ultra-
violet (UV) crosslinking and immunoprecipitation (CLIP)
[1, 2]. During the CLIP protocol, crosslinked protein–
RNA complexes are purified and the RNA fragments are
released by digesting the protein, resulting in RNAs with a
covalently bound peptide at the crosslink site. This is
followed by reverse transcription, during which the bound
peptide can lead to truncation of complementary DNAs
(cDNA) at the crosslink site. The CLIP protocol prepares
the cDNA library in a way that requires the reverse tran-
scriptase to read through this peptide, thereby generating
only ‘readthrough cDNAs’. Therefore, individual-nucleotide
resolution CLIP (iCLIP) was also developed to exploit the
‘truncated cDNAs’ [3]. The cDNA-starts of these truncated
cDNAs identify the nucleotide just downstream of the
crosslinked peptide. Even though iCLIP amplifies both
truncated and readthrough cDNAs, computational compar-
isons of CLIP and iCLIP cDNAs estimated that over 80% of
iCLIP cDNAs truncate at the crosslink sites of most RBPs
[4]. Recently, further variants were developed that also
amplify truncated cDNAs, including BrdU-CLIP [5], eCLIP
[6] and irCLIP [7]. Therefore, understanding the proportion
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and characteristics of truncated cDNAs in these protocols
is essential.
The computational methods that use cDNA-starts to
assign RNA-binding sites have been developed along
with iCLIP. However, a recent study observed that the
starts of long and short iCLIP cDNAs often map to
different genomic positions for several RBPs, which leads
to non-coinciding cDNA-starts [8]. Here, we focused on
experiments produced for polypyrimidine tract binding
protein 1 (PTBP1), eukaryotic initiation factor 4A-III
(eIF4A3) and the splicing factor U2 auxiliary factor
65 kDa subunit (U2AF2), which represent examples of
non-coinciding or coinciding cDNA-starts in introns or
exons. eIF4A3 is a component of the exon junction
complex (EJC). In vitro biochemical experiments with
several splicing substrates demonstrated that the site of
EJC deposition is normally expected at nucleotides −20
to −24 upstream of the exon-exon junction (–24..–
20 nt) [9]. However, further studies showed that the se-
quence and structure of a nascent messenger RNA
(mRNA) can shift EJC deposition as far as 10 nt away
from this expected site [10]. The non-coinciding cDNA-
starts in eIF4A3 iCLIP data produced by the previous
study were shifted upstream of this expected region and
it was proposed that the presence of non-coinciding
cDNA-starts might be related to this shift [8]. The study
concluded that the use of cDNA-starts may not be
appropriate in iCLIP whenever non-coinciding cDNA-
starts are prevalent.
To understand if cDNA-starts can be used to assign
RNA-binding sites, we further analysed the iCLIP data
with high frequency of non-coinciding cDNA-starts. We
first examined the position and prevalence of crosslink-
induced mutations to confirm previous findings, show-
ing that such mutations are generally >5-fold less com-
mon within iCLIP than CLIP cDNAs, regardless of the
presence of non-coinciding cDNA-starts [4]. Moreover,
we identified RNA motifs that are commonly associated
with crosslink sites and found them most highly
enriched at cDNA deletions in CLIP, and cDNA-starts in
iCLIP, eCLIP and irCLIP, even if non-coinciding cDNA-
starts are prevalent. Interestingly, when using the photo-
activatable 4-thiouridine (4SU)-based crosslinking in
combination with iCLIP, the motifs were more highly
enriched at cDNA-starts than at T-to-C transitions.
These results demonstrate that the cDNA-starts can
reliably be used to determine crosslink sites in iCLIP,
regardless of the crosslinking method.
Further analyses demonstrated that presence of
sequence and structural constraints at cDNA-ends is the
cause of the non-coinciding cDNA-starts. To experi-
mentally validate this finding, we produced additional
PTBP1 and eIF4A3 iCLIP experiments, which demon-
strate that the prevalence of the non-coinciding cDNA-
starts is directly correlated with the extent of cDNA-end
constraints. We show that the broad size range of iCLIP
cDNAs in these new experiments allows the cDNA-
starts to assign binding sites that align with the expected
binding motifs (PTBP1) or binding regions (eIF4A3). We
conclude that the use of the iCLIP cDNA-starts is ap-
propriate to assign the protein–RNA crosslink sites in
iCLIP and related methods.
Results
Crosslink sites are identified by cDNA-starts in iCLIP
The iCLIP protocol is composed of eight principal
experimental steps (Fig. 1a). First, cells or tissues are ir-
radiated with UV light, which can create covalent bonds
between an RBP and RNA. Cell lysates are then treated
with RNase and the crosslinked RNA fragments are
co-immunoprecipitated with the RBP. In the third
step, an oligonucleotide adapter is ligated to the 3′
end of RNA fragments. The immunoprecipitated com-
plexes are then separated and visualised by SDS-
PAGE and the protein–RNA complex is isolated in a
size-specific manner (Additional file 1: Figure S1).
The RBP is removed from the RNA through protein-
ase K digestion, leaving a small peptide at the cross-
link site. This impairs the reverse transcription and
commonly leads to the truncation of cDNAs at the
crosslinked peptide. Hence, iCLIP cDNAs start at the
nucleotide just downstream of the crosslinked peptide
and they end at the site of RNase cleavage.
To assess how variations in experimental conditions
affect the assigned binding sites, we compared published
and newly produced experiments for eIF4A3, PTBP1
and U2AF2. For the ease of comparisons, we numeric-
ally label the different experiments produced by the
same method (Fig. 1b). eIF4A3-iCLIP1 refers to data
generated in the previous study [8], while eIF4A3-
iCLIP2 and eIF4A3-iCLIP3 were newly produced by the
Le Hir and Ule labs, respectively. These are compared to
the published eIF4A3 CLIP [11]. The PTBP1-iCLIP1 also
refers to data generated in the previous study [12], while
PTBP1-iCLIP2 and PTBP1-iCLIP3 were newly produced
with deliberate protocol differences. Specifically, 4SU
was used to induce crosslinking and RNase I conditions
were adjusted in PTBP1-iCLIP2, and the 3′ dephosphor-
ylation step was omitted in PTBP1-iCLIP3. These are
compared to the published PTBP1 CLIP [13], eCLIP [6]
and irCLIP data [7]. Finally, we also compare the PTBP1
data to U2AF2 CLIP [14] and iCLIP [15].
It was proposed that presence of non-coinciding cDNA-
starts might indicate that some of these cDNAs have read
through the crosslink site during reverse transcription [8].
It has been shown previously that such readthrough
cDNAs often contain deletions, which are introduced into
cDNAs at the crosslink site during reverse transcription
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[4, 16]. We compared the proportion of cDNAs with dele-
tions in the different eIF4A3 datasets. Since the rate of se-
quencing errors rises with increasing cDNA length, we
only examined cDNAs shorter than 40 nt for this purpose.
Strikingly, a bimodal distribution of deletions is apparent
in all datasets, with one peak of deletions close to the
cDNA-starts (5..8th nt) and the second close to the
cDNA-centres (22..27th nt, Fig. 2a). Thus, the deletions
present in iCLIP show the same features as in CLIP and
likely inform on the presence of readthrough cDNAs.
Importantly, the proportion of deletions is lower by a
factor of 5 or more in all eIF4A3 iCLIP experiments
compared to CLIP, indicating that readthrough cDNAs
represent a minor proportion of iCLIP data.
We used sequence motifs as a second feature that can
serve as an identifier of crosslink sites. We defined these
Fig. 1 An overview of methods and experiments. a A simplified schematic of the iCLIP protocol [17]. Before, cells or tissues are irradiated with UV light,
which creates covalent bonds between proteins and RNAs that are in direct contact (step 1). After lysis, the crosslinked RNA is fragmented by limited
concentration of RNase I and RNA fragments are then co-immunoprecipitated with the RBP (step 2), followed by ligation of a 3′ adapter (step 3). After
SDS-PAGE purification (step 4), the crosslinked RBP is removed through proteinase K digestion and purification of RNA fragments (step 5). Reverse
transcription is performed with a primer that includes a barcode (orange) containing both an experimental identifier and a unique molecular identifier
(UMI) (step 6). The peptide that is on the crosslink site impairs reverse transcription and commonly leads to truncation of cDNAs at the crosslink site.
Therefore, two types of cDNAs are generated: truncated cDNAs and readthrough cDNAs. In iCLIP, the cDNA library is prepared in such a way that both
truncated and readthrough cDNAs are amplified (step 7). After PCR amplification and sequencing (step 8), both truncated and readthrough cDNAs are
present. b Table summarising the experiments used in this study. 4SU using 4SU combined with UV-A crosslinking, RNase optimised RNase digest
conditions including antiRNase inhibitor and increased RNase I concentration, dephospho omitting 3′ dephosphorylation
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sequence motifs based on analysis of eCLIP mock input
data that were produced along with the PTBP1 eCLIP
[6]. Even though no immunoprecipitation is done, the
eCLIP mock data represent RNA fragments crosslinked
to RBPs, because the lysate is loaded onto the gel and
transferred to a nitrocellulose membrane and the non-
crosslinked RNA migrates out of the gel or through the
membrane. Thus, eCLIP mock data represent RNAs
crosslinked to many different RBPs and should reflect
the sequence preferences at crosslink sites that are com-
mon to a mixture of RBPs. We identified 10 tetramers
that are enriched at cDNA-starts by a factor of 1.5 or
more compared to the 10 nt region upstream of the
cDNA-starts. Since they serve as a signature of crosslink
sites, we refer to them as ‘CL-motifs’ (for UV crosslink-
associated motifs). On one hand, these CL-motifs could
represent sequence preferences of one or few unknown
RBPs that dominate the eCLIP mock input data. On the
other hand, all CL-motifs are rich in uridines (see
‘Methods’), which would agree with the hypothesis of
preferred UV-C crosslinking to uridines [4]. The CL-
motifs are rich in polypyrimidine sequences that are
preferentially bound by PTBP1 and U2AF2 [18] and thus
it is expected that their enrichment should be especially
high at crosslink sites of these proteins. While no further
increase in CL-motif enrichment is seen at cDNA-starts
of PTBP1-eCLIP, it is reassuring to find their increased en-
richment at cDNA-starts of all PTBP1 and U2AF2 iCLIP
experiments (Fig. 2b, Additional file 1: Figure S2A).
We also found significant enrichment of CL-motifs at
cDNA-starts of all eIF4A3 iCLIP experiments (Fig. 2c,
Additional file 1: Figure S2B). eIF4A3 is not thought to
bind RNA with sequence specificity based on biochem-
ical and transcriptomic studies [9, 11, 19] and its
sequence-independent interaction with RNA is consist-
ent with the properties of DEAD-box proteins [20].
Moreover, we did not find any generic enrichment of
CL-motifs at nucleotides −20 to −24 upstream of the
exon-exon junctions, where EJC normally binds (data
not shown). Thus, it is most likely that CL-motifs only
reflect crosslinking preferences in the case of eIF4A3
iCLIP. In contrast to their enrichment at cDNA-starts of
all iCLIP experiments, CL-motifs are depleted from the
cDNA-starts of all CLIP experiments and instead they
are enriched within the sequence of CLIP cDNAs
(Fig. 2b, Additional file 1: Figure S2A, B). This agrees
with the expected prevalence of truncated cDNAs in
iCLIP and readthrough cDNAs in CLIP.
To further assess the validity of CL-motifs, we
exploited the bimodal distribution of deletions in the
cDNAs shorter than 40 nt, where one peak of deletions
is seen in the first 7 nt and a second peak around the
centre of cDNAs (Fig. 2a). We separated the cDNAs into
three classes: those with deletions in the first 7 nt, those
with deletions elsewhere and those with no deletions. If
cDNAs contain a deletion in PTBP1 and U2AF2 iCLIP,
CL-motifs are most highly enriched at the position of de-
letion, but not at cDNA-starts, which confirms that they
represent readthrough cDNAs (Additional file 1: Figure
S2C, D). However, in iCLIP of all three proteins, >90% of
cDNAs lack deletions; in these cDNAs, CL-motifs are
enriched exclusively at the cDNA-starts, confirming that
these largely correspond to truncated cDNAs (Fig. 2c,
Additional file 1: Figure S2C, D). In conclusion, analysis of
cDNA deletions and CL-motifs indicates that the position
of crosslink sites can generally be defined by cDNA-starts
in iCLIP.
cDNA-starts assign crosslink sites in iCLIP regardless of
the crosslinking method
We noticed that the cDNAs with deletions in eIF4A3-
iCLIP3 contain some CL-motif enrichment at cDNA-
starts in addition to the position of deletions (Fig. 2c).
To better understand this dual enrichment, we separated
those cDNAs with deletion before the 8th nt into three
classes (Fig. 2d). Fifty-six percent of cDNAs had the CL-
motifs overlapping with the deletion and these had no
additional motif enrichment at cDNA-starts. Thirteen
percent had CL-motifs at their start, but not at the pos-
ition of the deletion, and 31% had CL-motifs at neither
(See figure on previous page.)
Fig. 2 Crosslink-associated (CL)-motifs are enriched at cDNA deletions and cDNA-starts in iCLIP. a Proportion of eIF4A3 cDNAs with deletion at
each position relative to the cDNA-start. Only cDNAs shorter than 40 nt are examined. b Analysis of all PTBP1 experiments examined in this study
shows the proportion of cDNAs from each experiment that overlap with a CL-motif at each position relative to the cDNA-start. c Proportion of
eIF4A3-CLIP3 cDNAs that overlap with a CL-motif at each position relative to the cDNA-start. Only cDNAs shorter than 40 nt are examined; they
are divided into those lacking deletions or containing a deletion within the first 7 nt or anywhere in the remaining portion of the cDNA. d The
cDNAs of eIF4A3-CLIP3 containing a deletion within the first 7 nt are further sub-divided into three categories. First, cDNAs with CL-motifs between
the 1st and 10th nucleotide of the cDNA. Second, the remaining cDNAs that contain CL-motifs at the position 0. And third, all remaining cDNAs. The
proportion of cDNAs that overlap with a CL-motif at each position relative to the cDNA-start is then plotted for each sub-category. e Proportion of
PTBP1-iCLIP2 cDNAs that overlap with a CL-motif at each position relative to the cDNA-start. Only cDNAs shorter than 40 nt are examined and are
divided into those lacking T-to-C transitions or containing a transition within the first 7 nt or anywhere in the remaining portion of the cDNA. f The
cDNAs of PTBP1-iCLIP2 containing a T-to-C transition within the first 7 nt are further sub-divided into three categories. First, cDNAs with CL-motifs
overlapping the position 0. Second, the remaining cDNAs that contain CL-motifs between the 1st and 10th nucleotide of the cDNA. And third,
all remaining cDNAs. Visualisation as in (d). g Same as (c), but for PTBP1-iCLIP1. h Same as (d), but for PTBP1-iCLIP1
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position. A possible explanation for the dual enrichment
is that about 80% of deletions correspond to crosslink
sites and about 20% are a result of sequencing errors
within truncated rather than readthrough cDNAs. This
further indicates that readthrough cDNAs correspond to
a minor proportion of iCLIP reads.
Since cDNAs with deletions are rare in iCLIP, we per-
formed a new PTBP1-iCLIP experiment (PTBP1-iCLIP2)
in which we incubated cells with 4SU and induced
crosslinking with UV-A. We additionally optimised the
RNase conditions (see below). In PAR-CLIP, which origin-
ally introduced 4SU-mediated crosslinking, the presence
of T-to-C transitions indicates the position of crosslink
sites [21] and therefore we wished to examine if the same
applies to iCLIP when 4SU is used to induce crosslinking.
We used CL-motifs to examine the alignment of cDNA-
truncations and transitions to crosslink sites. The CL-
motifs are CU-rich (see ‘Methods’) and correspond well to
the known binding motifs of PTBP1 [18]. Thus, even if
4SU-mediated crosslinking has different sequence prefer-
ences, we expect that the CL-motifs should align well to
the crosslink sites of PTBP1 due to its binding prefer-
ences. The further benefit of using the same CL-motifs for
all analyses is that it allows us to directly compare the ex-
tent of their enrichment across all different experiments.
Notably, we obtained an unexpected misalignment be-
tween CL-motifs and transitions in PTBP1-iCLIP2: 57% of
cDNAs contained deletions, but CL-motifs were enriched
mainly at cDNA-starts, just like in PTBP1-iCLIP1 (com-
pare Fig. 2e and Additional file 1: Figure S2C). In 67% of
cDNAs with transitions, the position of the transition
mapped to the first few nucleotides close to the cDNA-
start. We therefore examined these cDNAs in more detail
by dividing them into three classes (Fig. 2f): 46% of these
cDNAs contain CL-motifs at the cDNA-start. Eighteen
percent contain CL-motifs at the site of transition ra-
ther than the cDNA-start. Thirty-six percent contain
no CL-motif at either position. A possible explanation
for this pattern of enrichment is that about 20% of
transitions correspond to crosslink sites and about
75% are a result of other causes. In conclusion, pres-
ence of transitions does not separate readthrough and
truncated cDNAs in iCLIP, since CL-motifs are
equally enriched at cDNA-starts of cDNAs containing
or lacking transitions.
While transitions do not overlap well with CL-motifs
in PTBP1-iCLIP2, the overlap is better with deletions in
PTBP1-iCLIP1. Even though only 1.4% of PTBP1-iCLIP1
cDNAs contain deletions (Fig. 2g), a greater proportion
contain CL-motifs at the position of the deletion than at
cDNA-starts (Fig. 2h). This indicates that deletions are
more reliable than transition to identify crosslink sites in
readthrough cDNAs, even when 4SU is used for cross-
linking in iCLIP. Taken together, analysis of deletions,
transitions and CL-motifs indicates that the incidence of
readthrough cDNAs is generally low and that the majority
of cDNAs truncate at crosslink sites in iCLIP regardless of
the crosslinking method.
Non-coinciding cDNA-starts result from constrained
cDNA-ends
In addition to the model of readthrough cDNAs, the
previous study also discussed an alternative model, in
which the non-coinciding cDNA-starts could originate
from constraints on RNase cleavage, particularly when
these are combined with the presence of long binding
sites [8]. We examined this alternative model in more
detail, since the prevalence of readthrough cDNAs in
iCLIP did not appear sufficient to account for the non-
coinciding cDNA-starts. We used the tool developed by
the previous study (iCLIPro) to examine the prevalence
of non-coinciding cDNA-starts in the PTBP1-iCLIP1
dataset. This tool compares the cDNA-start positions of
shorter and longer cDNAs and displays overlapping
starts by enrichment at position 0, while non-coinciding
starts are enriched at other positions. As seen previously
[8], we find that the PTBP1-iCLIP1 library contains
non-coinciding cDNA-starts (Fig. 3a). To understand if
the prevalence of non-coinciding cDNA-starts depends
on the length of binding sites, we first identified regions
on RNAs where cDNA-starts are significantly clustered,
and we refer to these as ‘crosslink clusters’ (see
‘Methods’ for more detail). Notably, the proportion of
non-coinciding cDNA-starts increases within crosslink
clusters that are longer than 5 nt (Fig. 3b) and this
increase is particularly dramatic in clusters longer than
30 nt (Fig. 3c). This analysis reveals that the non-
coinciding cDNA-starts originate mainly from long
binding sites.
To understand the possible causes and effects of the
constrained RNase cleavage, we examined the new
PTBP1-iCLIP2 experiment, in which we had also modi-
fied the conditions of RNase treatment: in this experi-
ment, we included an inhibitor of endogenous RNases
into the lysis buffer (antiRNase which does not inhibit
RNase I) and slightly increased the concentration of
RNase I compared to PTBP1-iCLIP1. In this way, we
hoped to ensure that RNase I, which is not thought to
have any sequence specificity, was responsible for frag-
menting the RNAs in PTBP1-iCLIP2. Interestingly, the
proportion of non-coinciding cDNA-starts is decreased
in PTBP1-iCLIP2 (Fig. 3d), and this decrease is particu-
larly apparent when analysing long crosslink clusters
(Fig. 3e, f ). In addition to the overlapping cDNA-starts,
the cDNA-ends in PTBP1-iCLIP2 also often overlap
with cDNA-starts (diagonal enrichment in Fig. 3d-f ).
Both RNase I and UV crosslinking require single-
stranded RNA and thus their similar RNA structure
Haberman et al. Genome Biology  (2017) 18:7 Page 6 of 21
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preferences are the likely cause for their increased
chance of overlap. Taken together, our results show that
the prevalence and position of non-coinciding cDNA-
starts can vary greatly between different iCLIP experi-
ments performed for the same RBP and thus they are
most likely a result of technical differences between
these experiments.
To understand the technical features that lead to the
non-coinciding cDNA-starts in PTBP1-iCLIP1, we
examined in more detail the long crosslink clusters in
which such cDNAs are most prominent. We restricted
all following analyses to the 1000 crosslink clusters with
the highest cDNA count to ensure that they have high
coverage of diverse cDNA lengths. We identified the
position within each crosslink cluster with the highest
count of cDNA-starts (cDNA-start peak) and the pos-
ition downstream of each crosslink cluster with the
highest count of cDNA-ends (cDNA-end peak). Next,
we categorised cDNAs based on their length and plotted
their starts and ends around cDNA-start peaks (Fig. 4a)
or cDNA-end peaks (Fig. 4b). As expected for long
crosslink clusters, cDNA-starts are broadly distributed
around the cDNA-start peaks. We measured the empir-
ical cumulative distribution of cDNA-starts around
cDNA-start peaks (Fig. 4a, c – inset), which demon-
strates that the distribution of cDNA lengths has a much
stronger influence on the position of cDNA-starts in
PTBP1-iCLIP1 (Fig. 4a) than PTBP1-iCLIP2 (Fig. 4c).
Strikingly, the cDNA-ends of all length categories precisely
overlap at the position of cDNA-end peaks in PTBP1-
iCLIP1 (Fig. 4b), while they are enriched over a broader
region downstream of the cDNA-end peaks in PTBP1-
iCLIP2 (Fig. 4d). Indeed, this tight constraint of cDNA-
ends in PTBP1-iCLIP1 reveals three distinct peaks of
cDNA-starts for each category of cDNA lengths (Fig. 4b),
while these peaks are less prominent in the PTBP1-iCLIP2
library, in which the fold change for cDNA-end constraint
is decreased by half (Fig. 4b, d – inner box plot). We
(See figure on previous page.)
Fig. 3 Proportion of non-coinciding cDNA-starts differs between PTBP1 iCLIP experiments. a Heatmap for PTBP1-iCLIP1 generated using the previously
developed software iCLIPro [8] to show the relative positioning of cDNA-starts of shorter iCLIP cDNAs (17–39 nt) compared to cDNA-starts of long
cDNAs (longer than 39 nt). b As in (a), but for cDNAs of PTBP1-iCLIP1 that overlap with 5–30 nt long crosslink clusters. c As in (a), but for cDNAs of
PTBP1-iCLIP1 that overlap with >30 nt long crosslink clusters. d As in (a), but for PTBP1-iCLIP2. e As in (a), but for cDNAs of PTBP1-iCLIP2 that overlap
with 5–30 nt long crosslink clusters. f As in (a), but for cDNAs of PTBP1-iCLIP2 that overlap with >30 nt long crosslink clusters
a b
c d
Fig. 4 Non-coinciding cDNA-starts are a result of constrained cDNA-ends. a The cDNA-starts (solid lines) and cDNA-ends (dotted lines) of PTBP1-iCLIP1 are
plotted around the cDNA-start peak that was identified within each of the 1000 > 30 nt long crosslink clusters that have the highest total cDNA count.
cDNAs are divided into four length categories: 17–29 nt, 30–34 nt, 35–39 nt and >39 nt. The inner plot shows the empirical cumulative distribution from
all four length categories in the region between –25 nt and 25 nt around cDNA-start peaks. b As in (a), but plotted around the cDNA-end peak that was
identified within the 30 nt downstream of each of the 1000 > 30 nt long crosslink clusters that have the highest total cDNA count. The inner box plot
shows the ratio of cDNA counts (log2) at the position 0 (overlapping with cDNA-end peak) compared to the average count of cDNAs in the region from
5 nt to 25 nt downstream of the cDNA-end peak (marked by horizontal arrow). c As in (a), but for PTBP1-iCLIP2. d As in (b), but for PTBP1-iCLIP2
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conclude that the presence of non-coinciding cDNA-
starts is reduced in PTBP1-iCLIP2 due to the decreased
constraints at cDNA-ends.
PTBP1 binding sites can be assigned correctly despite
non-coinciding cDNA-starts
Analysis of the PTBP1-iCLIP1 demonstrated that the
non-coinciding cDNA-starts are most enriched within
long crosslink clusters. Thus, we speculated that analysis
of long binding sites might detect non-coinciding
cDNA-starts also in those iCLIP datasets previously
analysed by the iCLIPro tool, even if they had not been
detected by iCLIPro. For example, U2AF2-iCLIP appears
to lack non-coinciding cDNA-starts when analysed by
iCLIPro [8] and so we looked at iCLIP data for this
protein in more detail.
Both PTBP1 and U2AF2 preferentially bind to pyrimi-
dine tracts (Y-tracts) [14, 15, 18] and therefore we
defined the coordinates of potential PTBP1 and U2AF2
binding sites independently of iCLIP data. Specifically,
we compared the crosslinking of these two proteins
across the longest computationally identified Y-tracts
that are annotated in the human genome as T-rich or
TC-rich ‘low complexity sequences’ and are located
mainly at deep intronic positions. Interestingly, PTBP1-
iCLIP1 and U2AF2-iCLIP have a similar presence of
non-coinciding cDNA-starts within these long Y-tracts.
The short iCLIP cDNAs identify the crosslink sites close
to the 3′ region of the Y-tracts, while longer cDNAs
identify crosslink sites that are located further towards
the 5′ region (Fig. 5a, b). These non-coinciding cDNA-
starts of all cDNA length categories correctly identify
crosslink sites, because they are enriched almost exclu-
sively within the Y-tracts, which these proteins are known
to bind (Additional file 1: Figure S3).
Notably, the cDNA-ends are constrained to positions
downstream of the Y-tracts both in PTBP1-iCLIP1 and
U2AF2-iCLIP (Fig. 5c, d). Since cDNA-ends represent
the sites of RNase cleavage, this most likely indicates
inefficient RNase cleavage within the Y-tracts. Thus, the
presence of non-coinciding cDNA-starts reflects
constrained positions of cDNA-ends. In this context, the
broad size range of iCLIP cDNAs is crucial to overcome
the constraints at cDNA-ends, thereby enabling the
non-coinciding cDNA-starts to detect crosslink events
across the long Y-tracts. Moreover, the long cDNAs are
particularly important, since they can truncate at cross-
link sites that are located far from the site of RNase
cleavage. In doing so, they identify crosslink sites across
the entire length of the long binding sites.
Our analysis of Y-tracts indicates that non-coinciding
cDNA-starts do not necessarily have a negative effect on
the assignment of binding sites. To examine this notion
more comprehensively, we compared the sequence
features of crosslink clusters defined by PTBP1-iCLIP1
and PTBP1-iCLIP2. First, we identified PTBP1-binding
motifs by searching for pentamers that are most highly
enriched around the cDNA-starts in PTBP1-iCLIP2 (see
‘Methods’). Then, we visualised the position of these
PTBP1-binding motifs around the crosslink clusters that
were identified by cDNA-starts in the different iCLIP,
eCLIP or irCLIP experiments (Fig. 5e). This confirmed
that enrichment of the PTBP1-binding motifs correctly
overlaps with the starts and ends of crosslink clusters
regardless of which crosslinking type or which variant of
library preparation protocol was used. Moreover, the
high prevalence of non-coinciding cDNA-starts in
PTBP1-iCLIP1 does not affect the high resolution of the
method. Taken together, we conclude that the use of
cDNA-starts is appropriate for the computational analysis
of data produced by iCLIP or any related method that is
capable of efficiently amplifying truncated cDNAs.
Efficient RNase I-mediated RNA fragmentation minimises
the cDNA-end constraints
The cDNA-end corresponds to the position where the
RNA fragment was cleaved by the RNase (Fig. 1a, step
2). As described earlier, we optimised the conditions of
RNase treatment in the PTBP1-iCLIP2 experiment to
ensure that RNase I is the primary cause of RNA frag-
mentation. This indicates that RNA fragmentation by
other factors might have caused the high cDNA-end
constraints in PTBP1-iCLIP1. To investigate this possi-
bility, we first assessed cDNA positions at the 3′ splice
sites, since these are subject to endogenous RNA cleav-
age by the spliceosome. While PTBP1 binds to Y-tracts
at specific 3′ splice sites to repress alternative splicing,
U2AF2 binds to most 3′ splice sites [14, 15, 18]. Inter-
estingly, a peak of cDNA-ends is present at the last
intronic nucleotide, even though most cDNA-ends are
in the exonic sequence (Fig. 6a). The U2AF2-iCLIP
cDNAs of all length categories that end in terminal part
of introns have non-coinciding cDNA-starts (Fig. 6b),
while the cDNAs that end in the exon have fully coin-
ciding cDNA-starts (Fig. 6c).
The intronic U2AF2-iCLIP cDNA-ends are con-
strained to the position where the 3′ splice site is
cleaved by the endogenous spliceosome. However, the
cDNA-ends in exons are not constrained, most likely
because they result from cleavage of pre-mRNA by
RNase I. To test this hypothesis, we exploited the fact
that intron lariats lack a phosphate at their 3′ end and
thus no 3′ dephosphorylation is needed at step 2 of the
protocol to detect them in iCLIP (Fig. 1a). We therefore
produced another PTBP1 iCLIP experiment (PTBP1-
iCLIP3), in which we omitted dephosphorylation from
step 2 and continued directly to ligation of the 3′
adapter in step 3 (Fig. 1a). Since RNA fragments cleaved
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at their 3′ end by RNase I contain a 3′ phosphate, they
were not ligated to the 3′ adapter (Fig. 1a, step 3) and
therefore only those RNA fragments cleaved by other
means were amplified in PTBP1-iCLIP3. Notably, both
in PTBP1-iCLIP1 and PTBP1-iCLIP3, the cDNA-ends at
3′ splice sites are strongly constrained to the end of in-
trons, while this constraint is minor in PTBP1-iCLIP2
(Fig. 6d–f ). Thus, non-coinciding cDNA-starts predom-
inate at 3′ splice sites in PTBP1-iCLIP1 and PTBP1-
iCLIP3, while in PTBP1-iCLIP2 most cDNA-starts
coincide in the region of 20 nt to 5 nt upstream of the
intron-exon junction. This suggests that the RNAs
overlapping with the 3′ splice sites were fragmented by
spliceosome-mediated cleavage in PTBP1-iCLIP1 and
PTBP1-iCLIP3 and by RNase I in PTBP1-iCLIP2 and in
U2AF2-iCLIP. It is this difference that appears to explain
the variation in the prevalence of non-coinciding cDNA-
starts at 3′ splice sites.
To further compare the characteristics at cDNA-ends,
we visualised the nucleotide composition of cDNA-ends
for the three PTBP1 iCLIP experiments. In PTBP1-
iCLIP2, for which we used the increased RNase I
concentration, we observed almost no sequence biases
at cDNA-ends, in agreement with the lack of sequence
specificity of RNase I (Fig. 6h). In contrast, a preference
for adenosines was observed at the cDNA-ends in
PTBP1-iCLIP1 and PTBP1-iCLIP3, suggesting that this
preference results from an RNase I-independent frag-
mentation of RNAs (Fig. 6g–i). Spliceosome-mediated
RNA cleavage contributes to only about 0.1% of these
fragments (Fig. 6j) and therefore the primary cause of
RNase I-independent fragmentation remains to be
identified. Nevertheless, we can clearly conclude that the
efficient use of RNase I avoids the constraints at cDNA-
ends in iCLIP and this decreases the incidence of non-
coinciding cDNA-starts.
Sequence or structure preferences of RNA fragmentation
can constrain the cDNA-ends
Both U2AF2 and PTBP1 primarily bind to pre-mRNAs
and therefore we also wished to assess the impact that
constraints at cDNA-ends may have on RBPs binding
mature mRNAs. For this purpose, we examined the
iCLIP and CLIP cDNA libraries produced for eIF4A3.
The position of cDNA-starts varies greatly between
different eIF4A3 experiments (Fig. 7a). As observed by
the previous study, the cDNA-starts in eIF4A3-iCLIP1
are shifted to positions upstream of the expected EJC-
binding region (yellow rectangle in Fig. 7a) [8]. In con-
trast, the cDNA-starts of eIF4A3-iCLIP2 and eIF4A3-
iCLIP3 overlap with the expected binding region. The
cDNA-starts of eIF4A3-CLIP are shifted upstream of
eIF4A3-iCLIP2 and eIF4A3-iCLIP3, which agrees with
the likely prevalence of truncated cDNAs in iCLIP and
readthrough cDNAs in CLIP.
Next, we asked how the position of cDNA-ends may
influence the position of cDNA-starts. For this purpose,
we first examined the positions of cDNA-ends by sum-
marising them across all exon-exon junctions. The
cDNA-ends in eIF4A3-iCLIP1 are highly enriched in a
region immediately downstream of the expected EJC-
binding region (mainly positions –18..0 nt relative to the
junctions), but they are also more broadly distributed
further downstream of the expected EJC-binding region,
including in the downstream exon (Fig. 7b). To under-
stand why the positions of cDNA-ends are so different in
eIF4A3-iCLIP1 compared to the remaining experiments,
we first identified the cDNA-end peak, corresponding to
the position with the highest count of cDNA-ends at each
junction. We then grouped all exon-exon junctions that
had the same position of the cDNA-end peak relative to
the junction. Both in eIF4A3-iCLIP1 and eIF4A3-iCLIP2,
each junction has a preferred position of cDNA-ends, in-
dicating that both experiments show a strong cDNA-end
constraint at individual junctions (marked by blue rect-
angle in Additional file 1: Figure S4A, B).
To further understand the causes for different cDNA-
end positions in eIF4A3-iCLIP1, we assessed the RNA
sequence and structure preference at cDNA-ends. The
cDNA-end peak in eIF4A3-iCLIP2, but not eIF4A3-
iCLIP1, coincides with a strong decrease in pairing prob-
ability (Additional file 1: Figure S4C, D). Since most
endonucleases cut at single-stranded RNA, this indicates
that the RNA fragments were cut at their 3′ end by an
endonuclease in eIF4A3-iCLIP2, while additional factors
may contribute to the RNA fragmentation in eIF4A3-
iCLIP1. In eIF2A3-iCLIP2, but not eIF4A3-iCLIP1, we
also observe a second peak of cDNA-ends precisely at
(See figure on previous page.)
Fig. 5 Non-coinciding cDNA-starts are required to map the crosslink sites within Y-tracts. a The cDNA-starts of PTBP1-iCLIP1 and CLIP experiments
are plotted around the ends of >35 nt Y-tracts that are annotated as T-rich or TC-rich low-complexity sequence in the human genome (hg19).
cDNAs of PTBP1-iCLIP1 are divided into four length categories: 17–29 nt, 30–34 nt, 35–39 nt and >39 nt. b Same as (a), but using U2AF2-iCLIP
and CLIP cDNAs. c Same as (a), but showing the positions of cDNA-ends. d Same as (b), but showing the positions of cDNA-ends. e Heatmap
showing the coverage of PTBP1-binding motifs at the PTBP1-iCLIP1, PTBP1-iCLIP2, PTBP1-eCLIP or PTBP1-irCLIP crosslink clusters that were defined
with a 3-nt clustering window. Each row shows the average coverage for 300 clusters of similar length, sorted from shortest to longest clusters.
The white line marks the nucleotide preceding the start and the nucleotide following the median end of all clusters that were combined in each
row. A colour key for the coverage per nucleotide of the PTBP1-binding motifs is shown on the right
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Fig. 6 Constrained cDNA-ends affect the cDNA-starts at 3′ splice sites. a The cDNA-starts (solid lines) and cDNA-ends (dotted lines) of U2AF2-iCLIP
are plotted around intron-exon junctions (position 0 being the first nucleotide of the exon). cDNAs are divided into three length categories: 17–29 nt,
30–34 nt and 35-39 nt; the distribution of all cDNAs together is shown in grey. b Same as (a), but using only cDNAs that end in the intron. c Same as
(a), but using only cDNAs that end in the exon. d Same as (a), but showing PTBP1-iCLIP1 cDNA-starts (full lines) and cDNA-ends (dotted lines). e Same
as (a), but showing PTBP1-iCLIP2 (using 4SU and optimised RNase conditions) cDNA-starts (full lines) and cDNA-ends (dotted lines). f Same as (a), but
showing PTBP1-iCLIP3 (omitting 3′ dephosphorylation) cDNA-starts (full lines) and cDNA-ends (dotted lines). g The composition of genomic nucleotides
around iCLIP cDNA-ends from PTBP1-iCLIP1. h Same as (g), but showing PTBP1-iCLIP2. i Same as (g), but showing PTBP1-iCLIP3. j Proportions of
cDNAs that map to introns which contain cDNA-ends at positions overlapping the last two nucleotides of introns. PTBP1-iCLIP1 and PTBP1-iCLIP2 are
compared to PTBP1-iCLIP3 iCLIP, which was performed without using PNK to dephosphorylate RNAs in step 2. This enriches for RNAs that contain a 3′
OH, which can occur when they are cleaved at their 3′ end independently of RNase I, such as the 3′ ends of intron lariats
a
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Fig. 7 A broad cDNA length range ameliorates the effects of constrained cDNA-ends. a The cDNA-starts of eIF4A3 iCLIP and CLIP experiments
are plotted around the 1000 exon-exon junctions with the highest number of cDNAs. b Same as (a), but showing cDNA-ends. c Heatmap
showing the position of cDNA-starts in eIF4A3-iCLIP1 around the 1000 exon-exon junctions with the highest number of cDNAs. Junctions are
sorted according to their cDNA-end peak position. Each row shows the average of cDNA counts at all junctions with a cDNA-end peak at the
indicated position. The values are normalised against the maximum value across all rows. On the right, the arrows mark parts of the figure in
which binding site assignment corresponds to the schematic shown in Fig. 8d. Coloured rectangles mark the main region of eIF4A3 crosslinking
(green), the expected EJC-binding region (yellow) and the position of the cDNA-end peak (blue). d Same as (c), but for eIF4A3-iCLIP2. The arrow in
the figure marks the 17 nt minimal distance between cDNA-starts and the expected EJC-binding region that is required for cDNA-starts to be able
to identify crosslink sites within the binding site. On the right, the arrows mark sections that correspond to the schematics shown in Fig. 8c, b
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the end of the exon (position –1) (Fig. 7b, Additional
file 1: Figure S4B). This probably reflects the deposition
of eIF4A3 on the spliced exon intermediate, as would be
expected based on previous biochemical studies [22–24].
The nucleotide composition at cDNA-ends also differs
between eIF4A3-iCLIP1 and eIF4A3-iCLIP2 (Additional
file 1: Figure S4E, F). These differences suggest that RNA
was fragmented by different mechanisms in eIF4A3-
iCLIP1 and eIF4A3-iCLIP2, but this remains to be fully
understood. Both eIF4A3-iCLIP2 and eIF4A3-iCLIP3 have
a strong enrichment of adenosine at the position following
the cDNA-end peak, indicating a potential for RNase I-
independent fragmentation (Additional file 1: Figure S4G).
However, the published eIF4A3-CLIP data used RNase T1
to fragment the RNA [11], which prefers to cut after the
guanosine, in agreement with a guanosine enrichment at
the position preceding the cDNA-end peaks (Additional
file 1: Figure S4H). Taken together, these findings indicate
that differences in RNA fragmentation conditions can
dramatically affect the structural and sequence features at
cDNA-ends in CLIP and iCLIP experiments and thus they
can constrain the positions of cDNA-ends in multiple
different ways. The impact of these constraints becomes
clear when aligning the junctions to the position of
cDNA-end peak, which demonstrates that the position of
each length category of cDNAs is defined by the position
of cDNA-ends (Additional file 1: Figure S4I–K).
To understand the constraints at cDNA-ends at the
level of individual exon-exon junctions, we examined
the exon-exon junctions with highest coverage of
cDNAs in greater detail. For this purpose, we focused on
the 1000 junctions with the highest cDNA count. This
demonstrates that the cDNA-ends are largely restricted
to a single position in the eIF4A3-iCLIP3 experiment,
while they are more variable in eIF4A3-iCLIP1. As a re-
sult, the cDNA-starts often coincide in eIF4A3-iCLIP1,
but are fully non-coinciding in eIF4A3-iCLIP3 (Add-
itional file 1: Figure S5). This again demonstrates that
the cDNA-end constraints are the primary cause of non-
coinciding cDNA-starts in iCLIP. These constraints
therefore need to be considered when interpreting the
position of binding sites assigned by iCLIP and related
methods.
A broad range of cDNA lengths compensates for the
constrained cDNA-ends
To understand how the constraints at cDNA-ends
influence the positions of cDNA-starts, we grouped
all exon-exon junctions that had the same position of
the cDNA-end peak and visualised the position of cDNA-
starts (Fig. 7c, d). This confirms that the position of
cDNA-ends (marked with blue rectangle) has a strong
effect on the position of the identified crosslink sites. Not-
ably, this effect is a lot more pronounced for eIF4A3-
iCLIP1, because cDNA-starts are enriched within a nar-
rowly defined distance from the cDNA-ends (Fig. 7c).
Analysis of the cDNA length distribution of the examined
experiments shows that eIF4A3-iCLIP1 has the largest pro-
portion of cDNAs that are shorter than 39 nt (58%) and
most of these cDNAs are in the range of 27–38 nt long
(Additional file 1: Figure S6). This indicates that a narrow
range of cDNA lengths dominates the eIF4A3-iCLIP1 li-
brary and this range of cDNA lengths defines the distance
at which cDNA-starts are positioned relative to cDNA-
ends. For comparison, only 36% of cDNAs are shorter than
39 nt in eIF4A3-iCLIP3 and the size distribution is more
even in eIF4A3-iCLIP2 (Additional file 1: Figure S6A). As a
result of the narrow range of cDNA-starts, the cDNA-
starts in eIF4A3-iCLIP3 rarely identify crosslink sites within
the expected EJC-binding region (marked by the yellow
rectangle).
In eIF4A3-iCLIP2, cDNAs have a broad range of
lengths, which allows to identify crosslink positions over
a broad area upstream of the cDNA-end peak, including
the expected EJC-binding region (Fig. 7d). Nevertheless,
eIF4A3-iCLIP2 does not identify crosslinking within the
expected EJC-binding region at a subset of exon-exon
junctions; at these junctions, the cDNA-ends are posi-
tioned closer than 17 nt to this region (top portion of
the heatmap in Fig. 7d). Since only cDNAs longer than
16 nt are normally isolated by the iCLIP procedure and
short cDNAs rarely map to a unique genomic position,
it would be very challenging to identify crosslink sites
closer than 17 nt to cDNA-ends. This demonstrates that
to comprehensively identify crosslink sites within the
binding region, the cDNA-ends should ideally be at least
17 nt away from the binding region.
In eIF4A3-iCLIP2, the large majority of cDNA-ends
are present more than 17 nt downstream of the expected
EJC-binding region (Fig. 7b). This decreased constraint
on cDNA-ends and the broad range of cDNA lengths
are the most likely reasons for the capacity of eIF4A3-
iCLIP2 to identify crosslink sites over the EJC-binding
region at most exon-exon junctions. Indeed, most cross-
linking in eIF4A3-iCLIP2 is seen within the expected
EJC-binding region, as well as approximately 10 nt on
each side of this region (marked with green rectangle in
Fig. 7d). In conclusion, the broad range of cDNA lengths
can overcome the cDNA-end constraints by producing
the non-coinciding cDNA-starts that can more compre-
hensively identify crosslink sites.
Discussion
Our study demonstrates that use of cDNA-starts is
appropriate to assign protein–RNA crosslink sites with
iCLIP and related methods, regardless of the crosslinking
method. Our findings also underscore the importance of
fully optimising the iCLIP conditions with the goal to
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produce a broad range of cDNA lengths with a minimal
cDNA-end constraint. We find that crosslink sites are
assigned by cDNA-starts even if non-coinciding cDNA-
starts are present, since these are a result of cDNA-end
constraints, which can have diverse causes (Fig. 8). The
constrained cDNA-ends become problematic when they
are present close to the binding site (Fig. 8c) or when a
narrow range of cDNA lengths dominates the library
(Fig. 8d). In these cases, only a portion of the binding
site might be assigned and this portion is likely to locate
at the upstream region of binding sites (Fig. 8c, d). In con-
trast, a broad range of cDNA lengths can compensate for
a
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Fig. 8 (See legend on next page.)
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cDNA-end constraints and in this case the presence of
non-coinciding cDNA-starts does not detrimentally influ-
ence binding site assignment (Fig. 8b).
A previous study suggested that the non-coinciding
cDNA-starts might reflect a prevalence of readthrough
cDNAs [8]. Here, we show four independent approaches
to examine non-coinciding cDNA-starts in PTBP1 and
eIF4A3 iCLIP, all of which lead us to conclude that non-
coinciding cDNA-starts are unrelated to readthrough
cDNAs. First, we show that CL-motifs are enriched
mainly at cDNA-starts in iCLIP, but not in CLIP. This
also applies to the PTBP1-iCLIP2 experiment in which
4SU was used for crosslinking. Second, we find a much
lower proportion of crosslink-induced deletions in
eIF4A3 iCLIP compared to CLIP data, as was also ob-
served previously for other RBPs [4]. Moreover, even
though the proportion of transitions is high in the
PTBP1-iCLIP2, analysis of CL-motifs indicates that a
minority of transitions correspond to crosslink sites,
while most crosslink sites overlap with cDNA trunca-
tions. This agrees with the enrichment of binding motifs
at cDNA-starts in CPSF30 iCLIP, where 4SU was also
used for crosslinking [25]. This conclusion is specific for
iCLIP, since transitions can precisely assign the crosslink
site in PAR-CLIP [21], because only readthrough cDNAs
are amplified and usually only one transition is present
in the sequenced read. Third, we show that the non-
coinciding cDNA-starts in iCLIP result from the con-
strained cDNA-ends and that their prevalence is greatly
diminished when RNase I is the primary source of RNA
fragmentation. Fourth, while cDNA-starts of read-
through cDNAs could lead to spurious assignment of
crosslink sites upstream of the expected binding regions,
we find that the binding sites are correctly assigned by
PTBP1-iCLIP1 as well as by eIF4A3-iCLIP2 and eIF4A3-
iCLIP3. Thus, we find that prevalence of non-coinciding
cDNA-starts is unrelated to the presence of readthrough
cDNAs.
The presence of non-coinciding cDNA-starts previ-
ously served as an argument for using cDNA-centres
instead of cDNA-starts because the cDNA-starts are
shifted to the region upstream of the expected binding
sites in eIF4A3-iCLIP1 [8]. However, we now find that
other eIF4A3 iCLIP experiments also contain non-
coinciding cDNA-starts, but their cDNA-starts correctly
identify crosslink sites; this indicates that the non-
coinciding cDNA-starts are not the cause of shifted
binding site assignment in eIF4A3-iCLIP1. We now
show that this shift is caused by the presence of cDNA-
ends just downstream of binding sites, which is unique
to eIF4A3-iCLIP1. We also show that the non-
coinciding cDNA-starts are an indirect signature of se-
quence and structure biases at cDNA-ends, which reflect
RNase preferences. It has recently been shown that the
sequence bias of RNases can be incorporated into
models that predict protein-RNA binding [26]. It re-
mains unclear what causes the unusually high con-
straints at cDNA-ends in some of the experiments.
Multiple sources of RNA fragmentation could lead to
such preferences, including the cleavage of intron-exon
boundaries upon splicing, specificity of RNA cleavage by
exogenous or endogenous RNases, RNA fragmentation
during sonication or spontaneous hydrolysis. Non-
specific RNases, such as RNase I, should be used instead
of the sequence-specific RNases, such as the RNase A,
T1 or micrococcal nuclease. Moreover, as we demon-
strate with the PTBP1-iCLIP2 experiment, it is import-
ant that cleavage by RNase I is the dominant source of
RNA fragments. The optimal RNase conditions can be
confirmed by visualisation of protein-RNA complexes
after their separation with SDS-PAGE, as in the pub-
lished guidelines [3, 17, 27].
We also show that additional aspects of the iCLIP
protocol need careful optimisation to avoid cDNA-end
constraints. The 3′ dephosphorylation of RNA frag-
ments needs to be efficient (Fig. 1, step 2), since this is
necessary for efficient 3′ adapter ligation to the RNA 3′
ends produced by RNase I (Fig. 1, step 3). While previ-
ous studies found sequence and structural biases in the
RNA ligase-mediated 3′ adapter ligation [28, 29], we
show that PTBP1-iCLIP2 cDNA-ends do not have much
sequence bias, indicating that RNA ligation is not the
reason for the constraints in the other experiments.
However, it is important that the ligation is efficient, so
(See figure on previous page.)
Fig. 8 A schematic explaining how different extents of cDNA-end constraints affect binding site assignment. a If the iCLIP library contains a broad
range of cDNA lengths and unconstrained positions of cDNA-ends, then crosslink sites are identified in an unbiased manner, allowing assignment
of the full binding site (RNA map at the bottom). The crosslink sites assigned by cDNA-starts are marked in red bars and a grey bar marks a crosslink site
that is incorrectly assigned by a readthrough cDNA. b If cDNA-ends are constrained, most likely as a result of biased RNase cleavage, then the resulting
cDNA-starts do not coincide. Nevertheless, if a broad distribution of cDNA lengths is available and the cDNA-ends are placed far enough from the
binding site, then crosslink sites can still be identified across the full binding site, allowing correct assignment, as was seen in the case of eIF4A3-iCLIP2
(Fig. 7d). c If cDNA-ends are constrained to a position very close to the binding site, then those cDNAs that truncate at crosslink sites in the 3′ region
of the binding site are too short to be isolated and mapped to the genome. Therefore, crosslink sites are identified only in the 5′ region of the binding
site, leading to an overly narrow assignment of binding sites, as was seen in some of the sites identified by eIF4A3-iCLIP1 and eIF4A3-iCLIP2 (Fig. 7c, d).
d If cDNA-ends are constrained and an iCLIP library contains a narrow distribution of cDNA sizes, then cDNA-end constraints lead to an overly narrow
assignment of binding regions, as was seen in the case of eIF4A3-iCLIP1 (Fig. 7c)
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that ideally most RNA fragments become ligated to the
3′ adapter, which minimises potential biases. Finally,
purification of cDNAs should be performed in a way
that maintains a broad range of cDNA lengths in the
final amplified library. This should ideally include isola-
tion of both short and long cDNAs to maximise map-
ping of crosslink sites that are located either close or far
from the site of RNase cleavage, respectively. Moreover,
it indicates that special procedures for genomic mapping
of short cDNAs may be beneficial; for example, due to
the problem that short reads often map at multiple
genomic positions, mapping of short cDNAs could be
narrowed down to the genomic regions where longer
cDNAs map. In sum, it is important to ensure that
RNase I is the primary source of RNA fragmentation,
that 3′ dephosphorylation of RNA fragments is efficient
and that the cDNA library has a broad range of cDNA
sizes.
We show that use of cDNA-starts is appropriate to as-
sign protein–RNA crosslink sites with iCLIP. Interest-
ingly, we find that the number of assigned crosslink
clusters can vary greatly between the different datasets
in a manner that does not necessarily correlate with the
number of unique cDNAs that are present in the library
(Figs. 1b, 5e). These differences might reflect variable
amounts of co-purified non-specific RNAs in the differ-
ent experiments, which could result from the use of dif-
ferent antibodies and purification conditions. To draw
more solid conclusions, direct comparisons between
multiple methods will need to be done for a larger num-
ber of diverse RBPs.
It is clear, however, that identification of long binding
sites can be particularly challenging. Presence of long
cDNAs is required to identify crosslink sites across the
complete length of long PTBP1 binding sites. Moreover,
RNase cleavage sites need to be far enough from the
EJC-binding site in order to identify contacts within 10
nt on either side of the expected EJC-binding region by
the eIF4A3 iCLIP. This is compatible with the previous
findings that the precise position of EJC binding can
vary between different junctions, which can be influ-
enced by RNA sequence and structure, or by other RBPs
that bind in the vicinity [10, 11, 19]. Moreover, crosslink
sites positioned further from the expected binding site
might reflect eIF4A3 interactions that are independent
of its DEAD-box domain. Thus, analysis of long binding
sites with iCLIP experiments can provide valuable in-
sights into mechanisms of protein-RNA complexes.
Conclusions
We find that the presence of non-coinciding cDNA-
starts in iCLIP is not a signature of readthrough cDNAs,
but instead reflects cDNA-end constraints. These can
particularly affect the assignment of long binding sites of
RBPs. To overcome these constraints, multiple tech-
nical aspects of iCLIP need to be optimised, including
the conditions of RNase fragmentation, RNA ligation
and cDNA purification. This produces cDNA libraries
with a broad cDNA length distribution and low
cDNA-end constraints, which are well suited for
assigning the complete RNA binding sites of RBPs.
These considerations apply to all protocols that amp-
lify truncated cDNAs, including iCLIP, eCLIP and
irCLIP, and they ensure that cDNA-starts comprehen-
sively identify protein-RNA crosslink sites across the
transcriptome.
Methods
iCLIP experiments
iCLIP experiments are based on the previously described
protocol [17] with minor modifications. In PTBP1-
iCLIP1 (which was already used for a previous publica-
tion [12]), no antiRNase was used and the concentration
of RNase I was 0.5 U/mL. In PTBP1-iCLIP2, 4SU was
used for crosslinking as previously described [17] and
the RNase conditions were optimised to ensure efficient
RNase I-dependent fragmentation. In detail, HEK293T
cells were grown on 10 cm2 dishes, incubated for 8 h
with 100 μM 4SU and crosslinked with 2× 400 mJ/cm2
365 nm UV light. Protein A Dynabeads were used for
immunoprecipitations (IP). Eighty microlitres of beads
were washed in iCLIP lysis buffer (50 mM Tris-HCl
pH 7.4, 100 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% so-
dium deoxycholate). For the preparation of the cell lys-
ate, 2 million cells were lysed in 1 mL of iCLIP lysis
buffer and the remaining cell pellet was dissolved in
50 μL urea lysis buffer (50 mM Tris-HCl, pH 7.4,
100 mM NaH2PO4, 7 M urea, 1 mM DTT). After the
pellet had dissolved, the mixture was diluted with CLIP
lysis buffer to 1000 μL, an additional centrifugation was
performed and the two lysates were pooled before pro-
ceeding (2 mL total volume). As control for purity of
protein–RNA complexes, we used a high-RNase condi-
tion for analysis by SDS-PAGE gel, but not for further
preparation of cDNA library (Additional file 1: Figure
S1A). For the full experiment, we incubated 2 mL of lys-
ate with 4 U/mL of RNase I and 2 μL antiRNase (1/
1000, AM2690, Thermo Fisher) at 37 °C for 3 min and
centrifuged (Additional file 1: Figure S1B). We took care
to prepare the initial dilution of RNase in water, since
we found that RNase I gradually loses its activity when
diluted in the lysis buffer. In total, 1.5 mL of the super-
natant was then added to the beads, incubated at 4 °C
for 4 h and cDNA library was prepared based on the
standard protocol. In PTBP1-iCLIP3, the dephosphoryla-
tion step was omitted from step 2 (Fig. 1a) and the rest
was same as the standard protocol.
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eIF4A3-iCLIP2 was performed from HEK293 cells
crosslinked with 0.15 mJ/cm2 254 nm UV light. To pre-
pare the cell lysate, the cells were lysed with 1 mL iCLIP
lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1%
NP-40, 0.1% SDS, 0.5% sodium deoxycholate, final
concentration 2 mg/mL) and sonicated (Bioruptor, 5 × 5 s
on/off). Two replicates were produced, one with 1 U/mL
and the other with 2 U/mL of RNase I in 1 mL of lysate.
The SDS-PAGE analysis showed the size of the resulting
protein-RNA complexes to be similar (Additional file 1:
Figure S1C) and therefore we grouped these two replicates
for all analyses of eIF4A3-iCLIP2. After RNase treat-
ment, the samples were centrifuged. For each IP,
100 μL of Protein G Dynabeads were washed in
iCLIP lysis buffer and incubated with the anti-eIF4A3
antibody produced in the Le Hir laboratory [11]. The
samples were rotated at 4 °C for 2 h. The beads were
then washed with high-salt washing buffer (50 mM
Tris-HCl pH 7.4, 1 M NaCl, 1% NP-40, 0.1% SDS,
0.5% sodium deoxycholate). After the first round of
washes, the samples proceed through 3′ adapter
addition, an additional phosphorylation (0.2 μL PNK,
0.4 μL cold ATP [1 mM], 0.4 μL 10× PNK buffer,
3 μL water). After SDS-PAGE separation, the guide-
lines recommend isolating radioactive RBP-RNA com-
plexes that migrate 20–100 kDa higher than the RBP
alone, which leads to isolation of RNA molecules of
50–300 nt. Since we expect that most cDNAs truncate at
crosslink sites within these RNA molecules, we prepared
the iCLIP library with a heterogeneous population of
cDNAs that were 30–140 nt long (Additional file 1:
Figure S1D). We then produced sequence reads of
150 nt using the Illumina MiSeq platform for PTBP1-
iCLIP2 and 120 nt using the Illumina HiSeq platform
for eIF4A3-iCLIP2, thereby obtaining sequences for
cDNAs up to a length of 139 or 109 nt, respectively
(after removal of adapters).
eIF4A3-iCLIP3 was performed from HeLa cells based
on the previously described protocol [17] with minor
modifications. Briefly, HeLa cells were grown on 10 cm2
dishes and crosslinked with 0.15 mJ/cm2 254 nm UV
light. Protein A Dynabeads were used for IPs. For each
IP, 40 μL of beads were washed in iCLIP lysis buffer and
incubated with 5 μL of anti-eIF4A3 antibody produced
in the Le Hir laboratory [11]. For the preparation of the
cell lysate, the cells were scraped from a 10 cm2 dish
and lysed in 1 mL of iCLIP lysis buffer, incubated with
of 1 U/mL of RNase I at 37 °C for 3 min and centri-
fuged. The supernatant was then added to the beads and
incubated at 4 °C for 2 h. Afterwards, the beads were
washed with IP buffer (10 mM Tris, 150 mM NaCl,
2.5 mM MgCl2, 1% NP-40), RIPA-S buffer (50 mM Tris,
1 M NaCl, 5 mM EDTA, 2 M urea, 0.5% NP-40, 0.1%
SDS, 1% sodium deoxycolate) and PNK buffer before
proceeding to the iCLIP protocol for cDNA library
preparation and Illumina HiSeq sequencing produced
50 nt sequence reads (Additional file 1: Figure S1E, F).
Computational analyses
All the source codes used for the analyses in this paper
are released under an open source license compliant
with OSI (http://opensource.org/licenses) and are
available at the GitHub (https://github.com/jernejule/
non-coinciding_cDNA_starts) and Zenodo repository
(https://zenodo.org/badge/latestdoi/57377213).
Trimming of the adapter sequences
Before mapping the cDNAs, we removed unique molecular
identifiers (UMIs) and trimmed the 3′ Solexa adapter se-
quence. Adapter sequences were trimmed with the FASTX-
Toolkit 0.0.13 adapter removal software, using the following
parameters: -Q 33 -a AGATCGGAAG -c -n -l 26.
Mapping of iCLIP sequence data
To map iCLIP sequence data for PTBP1 and all RBPs
other than eIF4A3, we used the UCSC hg19/GRCh37
genome assembly and the Bowtie2 version 2.1 alignment
software with default settings. More than 81% (1,642,850
of 2,007,824) and 85% (8,585,142 out of 9,634,025) of all
cDNAs from the published and newly generated iCLIP
data, respectively, mapped uniquely to a single genomic
position. To map the eIF4A3 iCLIP data, we compiled a
set of the longest mRNA sequence available for each
multi-exon gene from BioMart Ensembl Genes 79. We
mapped to these mRNAs with the Bowtie2 version 2.1
alignment software, allowing two mismatches. More
than 50% (11,935,475 of 23,040,243) of cDNAs from all
eIF4A3 iCLIP datasets mapped to a unique mRNA
position.
The first 9 nt of the sequenced iCLIP read correspond
to the barcode, which contains the experimental identi-
fier that allows to separate experimental replicates, and
the UMIs, which allow to avoid artefacts caused by vari-
able PCR amplification of different cDNAs (Fig. 1a, step 8,
orange) [3]. We used these UMIs to quantify the number
of unique cDNAs that mapped to each position in the
genome (for PTBP1) or transcriptome (for eIF4A3) by
collapsing cDNAs with the same UMI that mapped to the
same starting position to a single cDNA.
Definition of crosslink-associated (CL) motifs
We reasoned that sequence motifs enriched directly at
the starts of the mock eCLIP cDNAs might uncover
preferences of UV crosslinking, since they are thought to
represent a mixture of crosslink sites for many different
RBPs and thus they should not reflect sequence specificity
of any specific RBP [6]. We therefore examined occur-
rence of tetramers that overlapped with the nucleotide
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preceding the cDNA-starts (position –1 nt) in comparison
with the ones overlapping with the 10th nucleotide pre-
ceding the cDNA-starts (position –10 nt) in PTBP1 mock
input eCLIP. We excluded the TTTT tetramer from fur-
ther analyses, since it is often part of longer tracts of Ts,
and therefore its inclusion decreases the resolution of ana-
lysis. Thus, the tetramers that are enriched over 1.5-fold
at position –1 compared to –10 include TTTG, TTTC,
TTGG, TTTA, ATTG, ATTT, TCGT, TTGA, TTCT and
CTTT, and these were considered for all analyses of ‘CL-
motifs’.
Definition of crosslink clusters
The crosslink clusters were identified by False Discovery
Rate peak finding algorithm from iCount (https://
github.com/tomazc/iCount), by assessing the enrichment
of cDNA-starts at specific sites compared to shuffled
data as described previously [30], with the following add-
itional details. At each cDNA-start, the counts of all
cDNAs containing their cDNA-start at a maximum spa-
cing of 15 nt were summed up (or at 3 nt spacing for
Fig. 5e). Then crosslink clusters were defined by using
the cDNA-starts with counts that passed the false dis-
covery rate < 0.05 significance threshold (determined by
comparing the count distribution to shuffled data).
Neighbouring clusters that were less than 21 nt apart (or
3 nt apart for Fig. 5e) were then merged into single
clusters.
Definition of cDNA-start peak and cDNA-end peak
The peak position of cDNA-starts was identified by
comparing the counts at each cDNA-start and choosing
the position with the maximum count within each de-
fined region from the top 1000 exon-exon junctions that
contain the highest number of cDNAs. Peak positions
with a low number of cDNAs (less then median number
of all top cDNA-start peaks) were ignored. If more than
one position of cDNA-starts had equal count, then the
position with maximum count that was located closest
to the start of the defined region was chosen. The same
approach was used to define cDNA-end peaks.
Definition of PTBP1-binding motifs
To identify the motifs bound by PTBP1, we searched for
pentamers enriched in the region [–10..10] around the
cDNA-start peaks identified in each crosslink cluster
defined by PTBP1-iCLIP2. Sixty-nine pentamers had
enrichment z-score > 299 and were used as PTBP1-
binding pentamers for further analyses. Their sequences
are: TCTTT, CTTTC, TCTTC, CTTCT, TCTCT,
CTCTC, TTTCT, TTCTC, TTCTT, TTTTC, TCCTT,
CTCTT, ATTTC, TTCCT, CTTCC, TTTCC, CCTTT,
CTTTT, CCTTC, TCTGT, TTCTG, TCCTC, CTTCA,
ATCTT, TGTCT, TCTGC, CTCCT, CCTCT, GTCTT,
TCTAT, TCTCC, ATTCC, TTCTA, CTTTG, TATCT,
ACTTC, TTATC, CTTAT, CTATT, TTCAT, TTCCA,
TCTTG, TTGTC, TTGCT, CTCTA, CTCTG, TATTT,
TCCCT, TCATT, TTCCC, CATTT, ATTCT, TTTAC,
GTTCT, CTATC, TCATC, CTTTA, TGTTC, TATTC,
CATCT, TACTT, CTGTT, CTTGC, ACCTT, TTTCA,
TTTGT, TGTTT, CTTGT, ACTTT. All of these penta-
mers are enriched in pyrimidines, in agreement with
the known preference of PTBP1 for UC-rich binding
motifs [31].
Visualisation of cDNA distributions with the density
graphs (used in Figs. 4a–d, 5a–d, 6a–f, 7a and b,
Additional file 1: Figure 3A–E, Additional file 1: Figure 4I–K,
Additional file 1: Figure 5A and B)
All normalisations were performed in R (version 3.1.0)
together with the ‘ggplot2’ and the ‘smoother’ package
for the final graphical output. For the analysis of eIF4A3
iCLIP, each density graph (RNA map) shows a distribu-
tion of cDNA-starts and cDNA-ends relative to positions
of exon-exon junctions or end peaks in mRNAs. To
avoid any border effects, we examined only exon-exon
junctions within coding regions, excluding the first or
the last junction. The number of cDNAs starting or end-
ing at each position on the graph was normalised by the
number of all cDNAs mapped to representative mRNAs,
the mRNA length and the number of examined exon-
exon junction positions, as described below:
RNAmap n½  ¼ ððcDNAs n½ =sum cDNAsð ÞÞ
 length mRNAsð Þ=count exonexonjunctionsð Þ
where [n] stands for a specific position on the density
graph.
To draw the graph, we then used the Gaussian method
with a 5-nt smoothing window.
For the analysis of PTBP1 iCLIP and CLIP, each dens-
ity graph (RNA map) shows a distribution of cDNA-
starts and cDNA-ends relative to positions of its binding
sites, which were defined using the position of Y-tracts.
We obtained genomic positions of all TC-rich and T-
rich low complexity sequences that are present in
introns in protein-coding genes in the human genome
by using the UCSC table browser.
To avoid the effects of variable abundance of intronic
RNAs (and occasional presence of highly abundant non-
coding transcripts, such as snoRNAs), we then normal-
ised counts at each binding site by the density of cDNAs
in the same region. For this purpose, we examined the
region of the binding site, as well as 120 nt 5′ and 3′ of
the binding site, to find the nucleotide with the largest
count of cDNA-starts or ends (depending on whether
starts or ends were plotted on the graph), which is
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referred to as ‘MaxCount’. We thus obtained ‘Max-
Count-normalised cDNA counts’ at each position (which
were between 0 and 1). For drawing RNA maps, we
wished to examine the enrichment of cDNA counts
within binding sites compared to nearby regions outside
of binding sites. We therefore calculated the average
‘MaxCount-normalised cDNA counts’ at each position
across the evaluated binding sites and divided this count
at each position by the average ‘MaxCount-normalised
cDNA counts’ in the region 50–100 nt downstream of
the binding site, as described in the formula below:
RNAmap n½  ¼ average normalised cDNAs n½ 
= average normalised cDNAs
 50 100 nt downstream of the binding site½ 
where [n] stands for a specific position on the density
graph.
To draw the graph, we then used the Gaussian method
with a 10-nt smoothing window. The empirical cumulative
distribution (Fig. 4a, c) were generated in R with stat_ecdf
function from ggplot2 package by using frequency of raw
cDNA-start counts for each length category in region
25 nt upstream and downstream from cDNA start peak.
Assignment of the cDNA-end peak in eIF4A3 iCLIP
For cDNA-end peak assignment in eIFA3 iCLIP data, we
used exons longer than 100 nt that were in the top 50%
of the distribution of exons based on cDNA coverage.
This ensured that sufficient cDNAs were available for as-
signment of the putative binding sites. We then sum-
marised all cDNA-end positions in the region –20 to +25
around exon-exon junctions and selected the position
with the maximum cDNA count as the ‘cDNA-end peak’.
Analysis of pairing probability
Computational prediction of the secondary structure
around the cDNA-end peaks was performed using the
RNAfold program with the default parameters [32].
Analysis of cDNA transitions
Density of C-to-T transitions across cDNAs was
performed by using the samtools software with the follow-
ing parameters: samtools calmd –u –u genomic.fasta
input_BAM> BAM_with_transitions. This pipeline re-
places BAM format mapped cDNA sequences with transi-
tions relative to genomic reference. In the next step of the
following pipeline we used a custom python script
(available on github repository) that returns a density
array of C-to-T transitions for cDNAs that are shorter
than 40 nt. For the final visualisation of density graphs, we
used the same approach as for all other density figures
without additional normalisations.
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